🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/03/2000 | 58,84 | 66,67 | 56,14 | 66,44 | +15,45% | 17,89% | 152.926 |
| 30/03/2000 | 61,29 | 62,23 | 55,68 | 57,55 | -7,52% | 10,69% | 166.391 |
| 29/03/2000 | 65,74 | 66,20 | 61,53 | 62,23 | -4,32% | 7,12% | 118.729 |
| 28/03/2000 | 68,31 | 69,71 | 64,57 | 65,03 | -6,08% | 7,53% | 99.680 |
| 27/03/2000 | 69,48 | 71,82 | 68,31 | 69,25 | -0,34% | 5,05% | 49.426 |
| 24/03/2000 | 70,18 | 72,05 | 67,84 | 69,48 | +1,71% | 6,00% | 75.955 |
| 23/03/2000 | 73,92 | 74,39 | 67,61 | 68,31 | -7,59% | 9,18% | 107.882 |
| 22/03/2000 | 68,78 | 73,92 | 66,91 | 73,92 | +11,27% | 10,20% | 92.119 |
| 21/03/2000 | 65,27 | 66,91 | 60,36 | 66,44 | -1,39% | 10,04% | 140.156 |
| 20/03/2000 | 67,84 | 71,12 | 66,91 | 67,37 | -0,69% | 6,21% | 80.658 |
| 17/03/2000 | 67,84 | 74,39 | 67,84 | 67,84 | -5,54% | 9,66% | 68.315 |
| 16/03/2000 | 65,74 | 72,05 | 64,57 | 71,82 | +12,87% | 11,39% | 103.420 |
| 15/03/2000 | 67,61 | 70,18 | 63,63 | 63,63 | -5,88% | 9,69% | 148.919 |
| 14/03/2000 | 74,86 | 75,33 | 67,37 | 67,61 | -4,30% | 10,62% | 187.471 |
| 13/03/2000 | 68,54 | 79,07 | 67,61 | 70,65 | +2,03% | 16,72% | 220.680 |
| 10/03/2000 | 74,86 | 79,54 | 67,37 | 69,25 | -9,76% | 16,25% | 274.247 |
| 09/03/2000 | 81,88 | 84,22 | 75,80 | 76,73 | -5,75% | 10,29% | 113.573 |
| 08/03/2000 | 88,19 | 88,19 | 74,86 | 81,41 | -4,92% | 15,12% | 182.795 |
| 07/03/2000 | 97,79 | 99,19 | 84,22 | 85,62 | -10,07% | 15,31% | 192.868 |
| 06/03/2000 | 89,36 | 97,32 | 87,96 | 95,21 | +10,00% | 10,47% | 253.354 |
| 03/03/2000 | 82,35 | 86,79 | 81,18 | 86,56 | +6,63% | 6,82% | 145.205 |
| 02/03/2000 | 81,18 | 84,92 | 80,24 | 81,18 | +1,17% | 5,76% | 133.183 |
| 01/03/2000 | 81,64 | 87,73 | 79,07 | 80,24 | -1,44% | 10,60% | 129.576 |
| 29/02/2000 | 77,20 | 81,41 | 76,73 | 81,41 | +6,75% | 6,06% | 119.130 |
| 28/02/2000 | 74,86 | 78,37 | 74,39 | 76,26 | +1,24% | 5,31% | 107.668 |
| 25/02/2000 | 79,54 | 82,35 | 74,86 | 75,33 | -4,73% | 9,41% | 156.987 |
| 24/02/2000 | 80,94 | 85,39 | 78,60 | 79,07 | -0,59% | 8,38% | 129.362 |
| 23/02/2000 | 80,94 | 85,85 | 78,13 | 79,54 | +3,66% | 9,54% | 194.765 |
| 22/02/2000 | 87,26 | 88,19 | 74,16 | 76,73 | -12,53% | 16,09% | 377.774 |
| 18/02/2000 | 89,83 | 94,51 | 84,22 | 87,73 | +2,46% | 11,46% | 337.752 |